what is a glp-1 inhibitor The revolution: UAB researchers are discovering about how these drugs work Top GLP-1 Agonists Balance Weight

Henning RJ, Sawmiller DR

What Happens When You Stop Taking GLP-1 Medications

34 The AMPLITUDE-O trial demonstrated significant dose-dependent effects of efpeglenatide on HF hospitalisation in patients with T2D and CVD or renal disease, along with one risk factor

At the max dose (1.8 mg daily), liraglutide typically reduced HbAc by ~1.0% to 1.5% (depending on baseline) when added to metformin ( [102] ) ( [61] )

Weight changes may affect treatment eligibility, insurance coverage, and medical necessity documentation

Studies in rodents have demonstrated that GLP-1R agonists reduce hippocampal cell death by reducing the development of amyloid- plaques (McIntyre et al., 2013)